Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: Relevance for Parkinson's disease

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 25-31

  Hritcu, Lucian ^a   Ciobica, Alin ^a  

^a ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Lipopolysaccharide; Memory; Oxidative stress; Parkinson's disease

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; PERGOLIDE; SUPEROXIDE DISMUTASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN REGION; CAUSAL ATTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; SUBSTANTIA NIGRA; TASK PERFORMANCE; TEMPORAL CORTEX; WORKING MEMORY;

LIPOPOLYSACCHARIDE; MEMORY; OXIDATIVE STRESS; PARKINSON'S DISEASE;

ANIMALS; BEHAVIOR, ANIMAL; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; MICROINJECTIONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PERGOLIDE; RATS; RATS, WISTAR; ROTATION; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE; TEMPORAL LOBE;

EID: 84880926048     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.006     Document Type: Article

References (55)

1. Jung B.D., Shin E.-J., Nguyen X.-K.T., Jin C.-H., Bach J.-H., Park S.J., et al. Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochemistry International 2010, 56:229-244.
2. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. British Journal of Pharmacology 2007, 150:963-976.
3. Liu B., Hong J.S. Role of microglia in inflammation mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental 2003, 304:1-7.
4. Arimoto T., Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiology of Disease 2003, 12:35-45.
5. Miller R., James-Kracke M., Sun G., Sun A. Oxidative and inflammatory pathways in Parkinson's disease. Neurochemical Research 2009, 34:55-65.
6. Danielson S.R., Andersen J.K. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radical Biology & Medicine 2008, 44:1787-1794.
7. Koutsilieri E., Scheller C., Grunblatt E., Nara K., Li J., Riederer P. Free radicals in Parkinson's disease. Journal of Neurology 2002, 249:II1-II5.
8. Marshall K.A., Daniel S.E., Cairns N., Jenner P., Halliwell B. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease. Biochemical and Biophysical Research Communications 1997, 240:84-87.
9. Kurtz A.L., Kaufer D.I. Dementia in Parkinson's disease. Current Treatment Options in Neurology 2011, 13:242-254.
10. Collerton D., Burn D., McKeith I., O'Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is avisual-perceptual and attentional-executive dementia. Dementia and Geriatric Cognitive Disorders 2003, 16:229-237.
11. Janvin C.C., Larsen J.P., Salmon D.P., Galasko D., Hugdahl K., Aarsland D. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Movement Disorders 2006, 21:337-342.
12. Bronnick K., Emre M., Lane R. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry 2007, 78:1064-1068.
13. Hritcu L., Ciobica A., Stefan M., Mihasan M., Palamiuc L., Nabeshima T. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease. Neuroscience Research 2011, 71:35-43.
14. Aarsland D., Zaccai J., Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Movement Disorders 2005, 20:1255-1263.
15. Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004, 127:550-560.
16. Janvin C., Aarsland D., Larsen J.P., Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dementia and Geriatric Cognitive Disorders 2003, 15:126-131.
17. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysacchride-induced neurotoxicity in the rat brain: role of microglia. Journal of Neuroscience 2000, 20:6309-6316.
18. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
19. Bilbo S.D., Rudy J.W., Watkins L.R., Maier S.F. A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats. Behavioural Brain Research 2006, 169:39-47.
20. Berger J.R. GIC. Von's Economo's Encephalitis. Clinical neurovirology 2003, 523-542. Marcel Dekker, New York. A. Nath, R. Joseph (Eds.).
21. Niehaus I. Lipopolysaccharides induce inflammation-mediated neurodegeneration in the substantia nigra and cerebral cortex (a case report). New trends in Alzheimer and Parkinson related disorders 2004, 36-39. Monduzzi Editore, Bologna. I.F.A. Hanin, R. Cacabelos (Eds.).
22. Castaño A., Herrera A.J., Cano J., Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ. Journal of Neurochemistry 2002, 81:150-157.
23. Hernández-Romero MdC., Argüelles S., Villarán R.F., De Pablos R.M., Delgado-Cortés M.J., Santiago M., et al. Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. Journal of Neurochemistry 2008, 105:445-459.
24. Iczkiewicz J., Rose S., Jenner P. Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat. European Journal of Neuroscience 2005, 21:1911-1920.
25. Lima M.M.S., Reksidler A.B., Vital M.A. The neurobiology of the substantia nigra pars compacta: from motor to sleep regulation. Journal of Neural Transmission: Supplementa 2009, 73:135-145.
26. Hritcu L., Ciobica A., Artenie V. Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson's disease. Central European Journal of Biology 2008, 3:250-257.
27. Ciobica A., Hritcu L., Artenie V., Stoica B., Bild V. Effects of 6-OHDA infusion into the hypothalamic paraventricular nucleus in mediating stress-induced behavioral responses and oxidative damage in rats. Acta Endocrinologica - Bucharest 2009, 42:5-36.
28. Hald A., Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link. Experimental Neurology 2005, 193:279-290.
29. Swarnkar S., Tyagi E., Agrawal R., Singh M.P., Nath C. A comparative study on oxidative stress induced by LPS and rotenone in homogenates of rat brain regions. Environmental Toxicology and Pharmacology 2009, 27:219-224.
30. Paxinos G., Watson S. The rat brain in stereotaxic coordinates 2005, Academic Press, San Diego.
31. Zhou H.-F., Liu X.-Y., Niu D.-B., Li F.-Q., He Q.-H., Wang X.-M. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiology of Disease 2005, 18:441-449.
32. Santiago R.M., Barbieiro J., Lima M.M.S., Dombrowski P.A., Andreatini R., Vital M.A.B.F. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2010, 34:1104-1114.
33. Franklin J.M., Carrasco G.A., Moskovitz J. Induction of methionine sulfoxide reductase activity by pergolide, pergolide sulfoxide, and S-adenosyl-methionine in neuronal cells. Neuroscience Letters 2013, 533:86-89.
34. Fuller R.W., Clemens J.A. Pergolide: a dopamine agonist at both D1 and D2 receptors. Life Sciences 1991, 49:925-930.
35. Herrera-Marschitz M., Arbuthnott G., Ungerstedt U. The rotational model and microdialysis: significance for dopamine signalling, clinical studies, and beyond. Progress in Neurobiology 2010, 90:176-189.
36. Baluchnejadmojarad T., Roghani M., Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neuroscience Letters 2010, 480:206-210.
37. Jackson L.L. VTE on an elevated maze. Journal of Comparative Psychology 1943, 36:99-107.
38. Magen I., Fleming S.M., Zhu C., Garcia E.C., Cardiff K.M., Dinh D., et al. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. European Journal of Neuroscience 2012, 35:870-882.
39. McLaughlin B., Buendia M.A., Saborido T.P., Palubinsky A.M., Stankowski J.N., Stanwood G.D. Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments. PLoS ONE 2012, 7:e36340.
40. Hritcu L., Nabeshima T. Kainic acid lesion-induced spatial memory deficits of rats. Central European Journal of Biology 2009, 4:179-185.
41. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. Journal of Experimental Psychology: Animal Behavior Processes 1976, 2:97-116.
42. Foyet H.S., Hritcu L., Ciobica A., Stefan M., Kamtchouing P., Cojocaru D. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease. Journal of Ethnopharmacology 2011, 133:773-779.
43. Winterbourn C., Hawkins R., Brian M., Carrell R. The estimation of red cell superoxide dismutase activity. Journal of Laboratory and Clinical Medicine 1975, 85:337.
44. Sharma M., Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sciences 2002, 7:2489-2498.
45. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
46. Sakamoto T., Okaichi H. Use of win-stay and win-shift strategies in place and cue tasks by medial caudate putamen (MCPu) lesioned rats. Neurobiology of Learning and Memory 2001, 76:192-208.
47. Rao Y., Xiao P., Xu S.-T. Effects of intrahippocampal aniracetam treatment on Y-maze avoidance learning performance and behavioral long-term potentiation in dentate gyrus in rat. Neuroscience Letters 2001, 298:183-186.
48. Frank-Cannon T.C., Tran T., Ruhn K.A., Martinez T.N., Hong J., Marvin M., et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. Journal of Neuroscience 2008, 28:10825-10834.
49. Mizuno M., Yamada K., Olariu A., Nawa H., Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. Journal of Neuroscience 2000, 20:7116-7121.
50. Hritcu L., Cioanca O., Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012, 19:529-534.
51. Sriraksa N., Wattanathorn J., Muchimapura S., Tiamkao S., Brown K., Chaisiwamongkol K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evidence-based Complementary and Alternative Medicine 2012, 823206:9.
52. Cnubben N.H.P., Rietjens I.M.C.M., Wortelboer H., Van-Zanden J., Van Bladeren P.J. The interplay of glutathione related processes in antioxidant defense. Environmental Toxicology and Pharmacology 2001, 10:141-152.
53. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., et al. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mechanisms of Ageing and Development 1990, 51:283-297.
54. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. British Journal of Anaesthesia 2003, 90:221-232.
55. Aly H.A.A., Lightfoot D.A., El-Shemy H.A. Modulatory role of lipoic acid on lipopolysaccharide-induced oxidative stress in adult rat Sertoli cells in vitro. Chemico-Biological Interactions 2009, 182:112-118.